Serum interleukin-15 levels in cancer patients with ... - Semantic Scholar
Recommend Documents
multiple organ dysfunction syndrome (MODS), refractory shock and clinical signs of ..... (Syndrome of. Inappropriate Antidiuretic Hormone Secretion - SIADH).
Oct 3, 2014 - 2 Clinic of General Surgery, Acibadem Bursa Hospital, Bursa, Turkey. 3 Department of Internal Diseases, Acibadem University School of ...
We reviewed the literature regarding the serum levels of the enzymes aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase ...
Results: Serum levels of irisin were significantly lower in breast cancer patients compared to controls (2.47 ± 0.57 and ... A significant independent association between irisin and breast cancer was ..... anti-inflammatory properties [31].
Summary. Ghrelin is a new endogenous ligand for the growth hormone secretagogue receptor. It activates the release of growth hormone from the pituitary and it ...
Serum isoprostanes levels in patients after abdominal hysterectomy. Szymczyk G1, BeÅtowski J2*, Marciniak A2, Kotarski J1. 1 1st Department of Gynaecology, ...
Increased serum interleukin-6 levels in patients with hidradenitis suppurativa. Haoxiang Xu1,2, Xuemin Xiao3, Yanyan He1,2, Xiaofeng Zhang1,2, Chengrang ...
Mar 7, 2012 - maximal androgen blockade (MAB), obtained by the addition of an oral antiandrogen compared ..... Alternative nonsteroidal antiandrogen.
impact of breast surgery on the serum profiles of early breast cancer patients ..... on the serum proteome, and even less is known about how these effects may ...
Serum YKL-40 Levels in Patients with Gastric Cancer - SAGE ... › publication › fulltext › Serum-Y... › publication › fulltext › Serum-Y...by V Itik · 2011 · Cited by 12 · Related articlesDetermination of YKL-40 levels may serve as a valuable bioma
Restless leg syndrome (RLS) is a sensoryâmotor disorder characterized by intense, unpleasant .... with the use a mechanic sphygmomanometer after 15 minutes of rest. ..... Our results suggest a lower degree of predisposition to atherosclerosis in ..
levels of serum protein in a large series of patients with Cushing's syndrome (CS) have been lacking. We have now evaluated, retro- spectively, the levels of ...
CLINICAL CHEMISTRY, Vol. 41, No. 12, 1995. Serum Oncoproteins in Asbestosis Patients. Riitta Partanen,'. Heikki Koskinen,2 Panu Oksa,2 Karl Hemminki,'.
autologous peripheral blood stem cell transplantation. (PBSCT) and in healthy ... High-dose chemotherapy followed by peripheral blood. Nine patients with ...
Jul 9, 2016 - and total PANSS score in sarcosine group compared to placebo; however, ... between serum MMP-9 concentrations and PANSS scores in all ...
Jan 7, 2008 - Mira Rho, Mark A. Perazella, Chirag R. Parikh, Aldo J. Peixoto, and Ursula C. ..... Goldsmith SR: The effect of moderate hypotension on va-.
Oct 5, 2013 - *Corresponding author: Simona Ruta, Stefan S. Nicolau Institute of Virology, 285 Mihai Bravu Bvd, ..... Cho H, Lee HC, Jang SK, Kim YK.
and with MMSE scores from 27 to 30 (28.7±1.2), re- cruited from the local ..... A net flux of peripheral cholesterol in the form of 27-hydroxycholesterol, a side.
Mar 20, 2017 -
Department ofMedicine, St. Paul-Ramsey Medical Center,4 St. Paul, Minnesota 55101; Department ... Medical School, Minneapolis, Minnesota 554552.
özellikle küçük serebral hasarı gösteren biyokimyasal belirteçler alanında ... body
mass index (BMI)- and sex- matched healthy sub- jects served as controls .
patients with paraplegia or tetraplegia and 15 control subjects by radioimmuno ... Key words: osteocalcin-bone GLA protein; paraplegia; tetraplegia; bone.
Serum interleukin-15 levels in cancer patients with ... - Semantic Scholar
may act as an anti-cachexia cytokine preserving muscle mass and weight loss in animals bearing an experimental model of cachexia (15). Increased protein ...
ONCOLOGY REPORTS 28: 1443-1452, 2012
Serum interleukin-15 levels in cancer patients with cachexia PEDRO L. MARTÍNEZ-HERNÁNDEZ1, ÁNGEL HERNANZ-MACÍAS2, CARMEN GÓMEZ-CANDELA3, CRISTINA GRANDE-ARAGÓN2, JAIME FELIU-BATLLE4, JAVIER CASTRO-CARPEÑO4, ISABEL MARTÍNEZ-MUÑOZ2, LAURA ZURITA-ROSA3, MARTA VILLARINO-SANZ3, CONCEPCIÓN PRADOS-SÁNCHEZ5 and JOAQUÍN SÁNCHEZ GARCÍA-GIRÓN6 Departments of 1Internal Medicine, 2Biochemistry, 3Clinical Nutrition, 4Medical Oncology, 5 Pneumology, and 6Thoracic Surgery, La Paz University Hospital, E-28046 Madrid, Spain Received May 14, 2012; Accepted July 2, 2012 DOI: 10.3892/or.2012.1928 Abstract. Interleukin-15 (IL-15) has important anabolic effects on muscle protein metabolism through a decrease in the ATP-ubiquitin-dependent proteolytic pathway. The role of IL-15 in human cancer cachexia is unknown. The aim of this study was to assess the relationship between interleukin-15 (IL-15) in cancer patients with cachexia at diagnosis of malignancy and 8 weeks later. An observational study of 21 cancer patients (with and without cachexia) and 8 healthy subjects was conducted. Body composition was measured by leg-to-leg impedance. Serum IL-15 levels were assessed at baseline and after 4 and 8 weeks. Baseline IL-15 values were similar in cancer patients and in healthy subjects. Cancer patients with lower baseline levels of IL-15 (8 weeks was also required as well as a recent diagnosis of oncologic disease and no previous cancer therapy except for palliative treatment of pain. The study was approved by the Ethics Committee of the hospital. Written informed consent was obtained from all patients. Exclusion criteria were as follows: life expectancy
